How Lck and Fyn Kinases Affect Tau Phosphorylation in Alzheimer's Disease
Author Information
Author(s): Timothy ME Scales, Pascal Derkinderen, Kit-Yi Leung, Helen L Byers, Malcolm A Ward, Caroline Price, Ian N Bird, Timothy Perera, Stuart Kellie, Ritchie Williamson, Brian H Anderton, C Hugh Reynolds
Primary Institution: MRC Centre for Neurodegeneration Research, King's College London
Hypothesis
Lck and Fyn kinases have different effects on the phosphorylation of tau protein, which may influence Alzheimer's disease pathology.
Conclusion
Lck and Fyn have subtle differences in their properties as tau kinases, suggesting that Lck may play a unique role in Alzheimer's disease pathology.
Supporting Evidence
- Lck and Fyn both phosphorylate tau, but Lck shows a preference for phosphorylating tyrosines other than Tyr18.
- Mutating tyrosines in tau reduces its phosphorylation by Lck, indicating multiple phosphorylation sites.
- Phosphorylation of tau by Lck may contribute to the pathology of Alzheimer's disease.
Takeaway
This study looks at two proteins, Lck and Fyn, that can add special tags to another protein called tau. These tags might help us understand how tau behaves in diseases like Alzheimer's.
Methodology
The study used in vitro phosphorylation assays and co-transfection experiments in COS-7 cells to analyze tau phosphorylation by Lck and Fyn.
Limitations
The study primarily focuses on in vitro and co-transfection models, which may not fully represent in vivo conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website